Wellgistics Health, Inc. (NASDAQ:WGRX) | WebDisclosure

Switch to English

10069	Sociétés
205833	Mots-clés
136100	Articles
109143	Communiqués

Accueil
Sociétés
Wellgistics Health, Inc.

COMMUNIQUÉ DE PRESSE

publié le 12/11/2025 à 13:40, il y a 4 mois 11 jours

Wellgistics Health Launches EinsteinRx as the Premier AI Prescription Management Hub Solution to Integrate Physical and Technology Healthcare Infrastructure
Wellgistics Health, Inc. launches EinsteinRx™, a premier prescription management solution integrating physical & technology infrastructure for optimized healthcare delivery in the $634B US prescription drug market. Enables seamless flow of information from physician to pharmacy

Healthcare Delivery Wellgistics Health Inc. EinsteinRx Pharmacy IT Railroad Prescription Management
BRÈVE

publiée le 13/10/2025 à 14:05, il y a 5 mois 10 jours

Wellgistics Health annonce une restructuration clé de sa direction et de son conseil d'administration

Expertise Financière Restructuration Du Conseil D'administration Distribution Pharmaceutique Changements Exécutifs Stratégie D'IA
BRÈVE

publiée le 13/10/2025 à 14:05, il y a 5 mois 10 jours

Wellgistics Health Announces Key Executive and Board Restructuring

Financial Expertise Executive Changes Pharmaceutical Distribution Board Restructuring AI Strategy
COMMUNIQUÉ DE PRESSE

publié le 13/10/2025 à 14:00, il y a 5 mois 10 jours

Wellgistics Health Announces Executive Management and Board Changes
Wellgistics Health, Inc. announces re-appointment of Prashant Patel as President and Interim-CEO. Eric Sherb appointed Interim-CFO. Changes in Board of Directors and executive management

Board Of Directors Pharmaceutical Distribution Wellgistics Health Prashant Patel Eric Sherb
BRÈVE

publiée le 30/09/2025 à 14:05, il y a 5 mois 23 jours

Wellgistics Health collabore avec TheracosBio pour élargir l'accès aux médicaments contre le diabète

TheracosBio Distribution Pharmaceutique Médicaments Contre Le Diabète Wellgistics Santé Brenzavvy®
BRÈVE

publiée le 30/09/2025 à 14:05, il y a 5 mois 23 jours

Wellgistics Health Collaborates with TheracosBio for Expanded Diabetes Medication Access

TheracosBio Pharmaceutical Distribution Wellgistics Health Diabetes Medication Brenzavvy®
COMMUNIQUÉ DE PRESSE

publié le 30/09/2025 à 14:00, il y a 5 mois 23 jours

Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies
Wellgistics Health partners with TheracosBio to improve affordability and access to diabetes medication Brenzavvy in the U.S. healthcare system through their maker-to-taker platform and network of 6,500+ pharmacies

TheracosBio BRENZAVVY Pharmaceutical Distribution Wellgistics Health Diabetes Medication
BRÈVE

publiée le 26/09/2025 à 02:06, il y a 5 mois 27 jours

Wellgistics Health Announces $5 Million Public Offering Pricing

Public Offering Pharmaceutical Distribution Stock Warrants AI Services Wellgistics Health
BRÈVE

publiée le 26/09/2025 à 02:06, il y a 5 mois 27 jours

Wellgistics Health annonce le prix de son offre publique de 5 millions de dollars

Offre Publique Distribution Pharmaceutique Bons De Souscription D'actions Services D'IA Wellgistics Santé
COMMUNIQUÉ DE PRESSE

publié le 26/09/2025 à 02:01, il y a 5 mois 27 jours

Wellgistics Health Announces Pricing of $5 Million Public Offering
Wellgistics Health, Inc. (NASDAQ: WGRX) announces pricing of public offering of 7,142,862 shares of common stock at $0.70 per share. Gross proceeds expected to be $5 million. Offering by H.C. Wainwright & Co

Public Offering H.C. Wainwright & Co. Pharmaceutical Distribution Wellgistics Health WGRX

Les Echos

Publié le 23/03/2026 à 19:08, il y a 2 heures 5 minutes

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Publié le 23/03/2026 à 19:08, il y a 2 heures 5 minutes

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Publié le 23/03/2026 à 18:37, il y a 2 heures 36 minutes

ALTAREA : Déclaration d’opérations sur actions propres
Publié le 23/03/2026 à 17:45, il y a 3 heures 28 minutes

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Publié le 23/03/2026 à 17:45, il y a 3 heures 28 minutes

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 23/03/2026 à 14:05, il y a 7 heures 8 minutes

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Publié le 23/03/2026 à 14:00, il y a 7 heures 13 minutes

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Publié le 23/03/2026 à 13:05, il y a 8 heures 8 minutes

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Publié le 23/03/2026 à 12:32, il y a 8 heures 41 minutes

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Publié le 23/03/2026 à 12:30, il y a 8 heures 43 minutes

Digi Power X to Announce 2025 Year End Financial Results on March 31st

Voir tout ACCESSWIRE

EQS Group

Publié le 23/03/2026 à 21:05, il y a 8 minutes

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Publié le 23/03/2026 à 21:05, il y a 8 minutes

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Publié le 23/03/2026 à 21:00, il y a 13 minutes

Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Publié le 23/03/2026 à 20:55, il y a 18 minutes

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable
Publié le 23/03/2026 à 20:23, il y a 50 minutes

Full Year 2025 Financial Results